cephalosporin c has been researched along with Infections, Vibrio in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavin, HE; Satchell, KJF; Trinh, SA | 1 |
| Darboe, KS; Jang, HC; Jung, SI; Kang, SJ; Kim, SE; Kim, UJ; Oh, TH; Park, KH; Shin, HY; Shin, SU | 1 |
| Brown, AM; Luscombe, GM; Mendis, K; Wong, KC; Wong, SJ | 1 |
| Chan, KS; Chao, WN; Chen, CC; Chen, SC; Lee, MC; Lee, YT; Lin, DB; Tsai, SJ; Wang, PH | 1 |
| Chang, KJ; Chiu, CH; Chiu, S; Jaing, TH; Lin, TY | 1 |
| Chang, MC; Chuang, YC; Huang, KY; Ko, WC; Lee, CL; Tang, HJ | 1 |
| Fujiyama, S; Tanaka, M | 1 |
| Lim, TK; Stebbings, AE | 1 |
1 review(s) available for cephalosporin c and Infections, Vibrio
| Article | Year |
|---|---|
[Vibrio vulnificus infections].
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Risk Factors; Seasons; Sepsis; Skin Diseases, Bacterial; Tetracyclines; Vibrio; Vibrio Infections | 1998 |
7 other study(ies) available for cephalosporin c and Infections, Vibrio
| Article | Year |
|---|---|
Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.
Topics: Animals; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Doxycycline; Drug Synergism; Drug Therapy, Combination; Female; Foodborne Diseases; Humans; Mice; Seafood; Sepsis; Vibrio Infections; Vibrio vulnificus | 2017 |
Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Republic of Korea; Retrospective Studies; Sepsis; Treatment Outcome; Vibrio Infections; Vibrio vulnificus; Young Adult | 2019 |
Antibiotic use for Vibrio infections: important insights from surveillance data.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Female; Humans; Male; Middle Aged; Odds Ratio; Penicillins; Quinolones; Survival Analysis; Tetracycline; United States; Vibrio; Vibrio Infections | 2015 |
Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Fasciitis, Necrotizing; Female; Fluoroquinolones; Humans; Male; Middle Aged; Minocycline; Treatment Outcome; Vibrio Infections; Vibrio vulnificus | 2012 |
Necrotising fasciitis caused by Vibrio vulnificus in a child without known risk factors.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Combined Modality Therapy; Debridement; Doxycycline; Drug Therapy, Combination; Fasciitis, Necrotizing; Humans; Male; Risk Factors; Tomography, X-Ray Computed; Vibrio; Vibrio Infections | 2002 |
In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Colony Count, Microbial; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Minocycline; Survival Analysis; Time Factors; Vibrio Infections; Vibrio vulnificus | 2002 |
Fulminant necrotising fasciitis caused by Vibrio parahaemolyticus.
Topics: Aged; Animals; Anti-Bacterial Agents; Bacteremia; Brachyura; Ceftazidime; Cephalosporins; Debridement; Doxycycline; Drug Therapy, Combination; Fasciitis, Necrotizing; Humans; Male; Seawater; Vibrio Infections; Vibrio parahaemolyticus | 1999 |